ALEXANDRIA, Va., April 2 -- Albany Molecular Research, Albany, New York, has been assigned a patent (8,993,765) developed by Matthew D. Surman, Albany, New York, Peter R. Guzzo, Niskayuna, New York, and Emily Freeman, Guilderland, New York, for "tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof."

The patent application was filed on Dec. 20, 2011 (13/331,814). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=P . . .